2023 annual financial data
Immix Biopharma 2023 Operating margin
Immix Biopharma 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -16,141,113 USD and net income was -15,426,048 USD.
Operating cash flow was -11,371,438 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -16,141,113 USD
- Net income
- -15,426,048 USD
- Operating cash flow
- -11,371,438 USD